Public Health Office of Asella, Bureau of Oromiya Health, Asella, Ethiopia.
Department of Public Health, University of Arsi, Asella, Ethiopia.
BMC Infect Dis. 2024 Oct 7;24(1):1115. doi: 10.1186/s12879-024-10003-0.
Cervical cancer is the predominant form of cancer in Ethiopia, accounting for the majority of malignant cases. Women account for two-thirds of cancer-related deaths in the country. Cervical cancer screening (CCS) can help prevent disease development, but screening rates are unacceptably low. The greatest number of women were in the most vulnerable group, and the availability of wheal data on their use of CCSs was limited. This study aimed to evaluate the use of CCS and the factors that influence its use among HIV-positive women receiving antiretroviral therapy at public health facilities.
This study used a cross-sectional study design. A total of 396 (97.5%) HIV-positive women participated in this study between March 10 and May 30, 2023. Participants enrolled in public health facilities in Asella town were selected through systematic random sampling, and data were collected through on-site interviews using a pretested, structured questionnaire. The data were analysed using the Statistical Package for Social Science, Version 26. Logistic regression analysis was used to identify the determining factors.
The findings from this study indicated that 30.3% of individuals used cervical cancer screening services. Those women who had knowledge about cervical cancer had a 2.54 times greater likelihood of receiving CCS than those who were not informed (adjusted odds ratio [AOR] = (2.54; 95% confidence interval [CI]: 1.42-4.56). Women with a history of sexually transmitted diseases were twice as likely to use CCS as those without such a history (AOR = 2.05, 95% CI = 1.13-3.73). Furthermore, women with a positive attitude towards CCS were found to be significant predictors of utilisation, showing a greater than threefold greater likelihood of using these services (AOR = 3.21; 95% CI: 1.78-5.81).
The proportion of HIV-positive women who underwent cervical cancer screening (CCS) was significantly lower than the recommended guideline of 80%. To enhance the uptake of screening among women with HIV, healthcare professionals should focus on enhancing awareness about cervical cancer, improving attitudes towards CCS, and advancing knowledge about the disease. Healthcare providers' collaboration with both government and nongovernmental stakeholders plays a crucial role in addressing the challenges of accessibility and attendance at screening services.
在埃塞俄比亚,宫颈癌是最主要的癌症类型,占恶性病例的大多数。该国三分之二的癌症相关死亡由女性造成。宫颈癌筛查(CCS)有助于预防疾病发展,但筛查率低得令人无法接受。大多数女性处于最脆弱的群体中,关于她们使用 CCS 的情况的可用数据有限。本研究旨在评估在接受抗逆转录病毒疗法的艾滋病毒阳性妇女中使用 CCS 的情况以及影响其使用的因素,这些妇女在公共卫生机构接受治疗。
本研究采用了横断面研究设计。2023 年 3 月 10 日至 5 月 30 日期间,共有 396 名(97.5%)艾滋病毒阳性妇女参与了这项研究。通过系统随机抽样选择在阿塞拉镇公共卫生设施登记的参与者,并通过现场访谈使用预测试、结构化问卷收集数据。使用社会科学统计软件包 26 版进行数据分析。使用逻辑回归分析确定决定因素。
本研究发现,30.3%的人使用了宫颈癌筛查服务。那些对宫颈癌有认识的女性接受 CCS 的可能性是没有得到通知的女性的 2.54 倍(调整后的优势比 [AOR] =(2.54;95%置信区间 [CI]:1.42-4.56)。有性传播疾病史的女性使用 CCS 的可能性是没有此类病史的女性的两倍(AOR = 2.05,95%CI = 1.13-3.73)。此外,对 CCS 持积极态度的女性被发现是利用这些服务的重要预测因素,使用这些服务的可能性增加了三倍以上(AOR = 3.21;95%CI:1.78-5.81)。
接受宫颈癌筛查(CCS)的艾滋病毒阳性妇女比例明显低于 80%的建议准则。为了提高艾滋病毒感染妇女对筛查的接受程度,医疗保健专业人员应重点提高对宫颈癌的认识,改善对 CCS 的态度,并增进对该疾病的了解。医疗保健提供者与政府和非政府利益攸关方的合作对于解决获取和参加筛查服务的挑战至关重要。